Generate an explanation for the given claim using the provided supporting material from the paragraph. Please consider the following points while generating an output. 1) The claim will always have supporting proof in the paragraph, and the paragraph will have a clear point of view supporting the claim. 2) There can be instances where direct correlation to the claim is not available. Make use of the sentences in the paragraph to provide a corresponding output supporting the claim. 3) The explanation should be at least one and at most twelve sentences long.

Input: Consider Input: Paragraph: A 38-year-old man from Zunyi city died last Thursday, Xinhua said, citing health authorities in Guizhou. Xinhua said it was the first human case of H7N9 in Guizhou this year. Last Friday, China said a 38-year-old man in eastern Fujian province died from H7N9. The World Health Organisation (WHO) said last week that seven more people in China had been found to be infected with the H7N9 strain of bird flu in the previous week, taking to around 150 the total number of cases so far. The H7N9 bird flu emerged last year in China and has infected around 150 people there and in Taiwan and Hong Kong, killing at least 45 of them. Experts say there is no evidence as yet of any easy or sustained person-to person transmission of the strain. But an early scientific analysis of probable transmission of the new flu from person to person, published last August, gave the strongest proof yet that it can at times jump between people and so could cause a human pandemic. The WHO said the source of the human infections was still being investigated. It stressed that it does not advise any special screening for people going in and out of China, nor does it recommend any travel or trade curbs. Claim: China reports second H7N9 bird flu death in a week.

Output: China reported one more death from the H7N9 strain of bird flu in southwestern Guizhou province, state news agency Xinhua said on Monday, in the second death from the virus in the past week.


Input: Consider Input: Paragraph: The bulk of the money will come from Teva Pharmaceutical Industries Ltd. and its affiliates for paying to delay a generic narcolepsy drug, Provigil, from entering the market for nearly six years. Teva is paying $69 million, which Becerra says is the largest pay-for-delay settlement received by any state. Such agreements let the developer of brand name drugs keep their monopolies over the drugs after their patents expire, thereby letting them continue to charge consumers higher prices. The drug developer pays the generic manufacturer to keep the cheaper version of the drug from entering the marketplace for an agreed period of time. Teva said the money will come from a pre-existing fund that was created in 2015 as part of the company’s settlement with the U.S. Federal Trade Commission over similar claims, and it will not make any additional payments. Becerra said such agreements can force consumers and the health care market to pay as much as 90% more than if there were generic alternatives. More than $25 million of the settlement will go to a consumer fund for California residents who purchased Provigil, Nuvigil or Modafinil between 2006 and 2012. “No one in America should be forced to skip or ration doses of medicine that they need ... and certainly not because a drug company is colluding to keep the price of your drug artificially high even when cheaper options could be available. But that’s what’s happening,” Becerra said. The second, $760,000 settlement is with Teva, Endo Pharmaceuticals and Teikoku Pharma USA over keeping a genetic alternative to the pain patch Lidoderm from entering the market for nearly two years. Teva said it is paying $200,000 to cover the state’s legal costs after settling similar federal claims earlier this year. Neither Endo nor Teikoku responded to requests for comment. Both settlements bar the companies from pay-for-delay agreements for several years. Teva is agreeing to not to enter any such agreements for 10 years, while Endo Pharmaceuticals has an eight-year agreement and Teikoku a 20-year injunction. Teva said the restriction is identical to its federal consent decree. Becerra also backed pending legislation, AB824 by Democratic Assemblyman Jim Wood of Santa Rosa, that would ban such agreements. The measure would require pharmaceutical companies to prove that their agreements are not anticompetitive. It passed the Assembly 56-0 in May and is awaiting a vote in the Senate. Pharmaceutical companies oppose the bill, arguing the Federal Trade Commission already does this monitoring. ___ This story has been corrected to say that while there are four settlement agreements, they involve only three companies. Claim: 3 companies pay California $70 million for delaying drugs.

Output: Three pharmaceutical companies collectively are agreeing to pay California nearly $70 million to settle allegations that they delayed drugs to keep prices high, California Attorney General Xavier Becerra said Monday.


Input: Consider Input: Paragraph: The 18,000-square-foot (1,700-square-meter) clinic in Fairview Heights, 12 miles (19 kilometers) east of St. Louis, will provide abortion services as well as family planning when it opens in mid-October, Planned Parenthood officials said at a news conference Wednesday. “While health care access in Missouri continues to hang on by a thread, Illinois is well-positioned to serve as a health care hub in the region,” said Yamelsie Rodriguez, president and CEO of Planned Parenthood of the St. Louis Region and Southwest Missouri. Planned Parenthood has been battling Missouri’s health department for months to try and keep open its St. Louis clinic. The state has refused to renew its license to perform abortions, citing concerns that include “failed abortions” that required additional surgeries. Missouri’s Administrative Hearing Commission is deciding the fate of the St. Louis clinic. Meanwhile, Missouri women have been increasingly getting abortions at the Hope Clinic for Women in Granite City, Illinois, another St. Louis suburb. Deputy Director Alison Dreith said 58 percent of the abortions performed at the Hope Clinic through August of this year involved Missouri women, and 37 percent were women from Illinois. Missouri is among several conservative states to pass new restrictions on abortions in the hope that the increasingly conservative U.S. Supreme Court will eventually overturn Roe v. Wade. Republican Gov. Mike Parson signed legislation in May banning abortions at or beyond eight weeks of pregnancy, with exceptions for medical emergencies but not for rape or incest. A federal judge in August temporarily blocked implementation of the law until the legal challenge plays out in court, which could take several months. During an annual inspection of the St. Louis clinic in March, Missouri health investigators cited numerous concerns, including reports of failed abortions. Planned Parenthood said it has already addressed those concerns and defended its clinic. It claims the state is using the licensing process as an excuse to stop abortions. The state initially let the clinic’s abortion license lapse at the end of May, then announced more definitively in June that it would not renew the license. The clinic remains open while the hearing commission decides its fate. Planned Parenthood officials say construction of the Fairview Heights clinic began last year, but details weren’t released until near completion to avoid protesters and potential construction delays. Claim: New abortion clinic being built in Illinois, near St. Louis.


Output: Planned Parenthood has quietly been building a new abortion clinic in Illinois, just across the Mississippi River from St. Louis, as women concerned about the uncertain future of Missouri’s sole abortion clinic flock across the state line.